BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 18495651)

  • 21. Effect of antifungal treatment in a murine model of blastoschizomycosis.
    Serena C; Mariné M; Marimon R; Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2007 Jan; 29(1):79-83. PubMed ID: 17134881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of activity of amphotericin B in systemic murine fusarial infection.
    Anaissie EJ; Hachem R; Legrand C; Legenne P; Nelson P; Bodey GP
    J Infect Dis; 1992 Jun; 165(6):1155-7. PubMed ID: 1583339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined therapy against murine-disseminated infection by Fusarium verticillioides.
    Ruíz-Cendoya M; Pastor J; Guarro J
    Mycopathologia; 2011 Mar; 171(3):171-5. PubMed ID: 20853029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
    Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
    J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of antifungal treatments for murine fusariosis.
    Spellberg B; Schwartz J; Fu Y; Avanesian V; Adler-Moore J; Edwards JE; Ibrahim AS
    J Antimicrob Chemother; 2006 Nov; 58(5):973-9. PubMed ID: 16973654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
    Selleslag D
    Acta Biomed; 2006; 77 Suppl 2():32-5. PubMed ID: 16918066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
    Najvar LK; Bocanegra R; Wiederhold NP; Lambros C; Najarian N; Patterson TF; Graybill JR
    Clin Microbiol Infect; 2008 Jun; 14(6):595-600. PubMed ID: 18397335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
    Muramatsu T; Ueki T; Ohashi K; Negishi K; Suzuki T; Shitara M; Honma M; Ito T; Sakai M; Yamashita T; Akiyama H; Sakamaki H
    Rinsho Ketsueki; 2006 Aug; 47(8):753-7. PubMed ID: 16986714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
    Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J
    J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
    Clemons KV; Schwartz JA; Stevens DA
    Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternatives to amphotericin B for Candida rugosa infection.
    Hernandez S; Gonzalez GM; McCarthy DI; Colombo AL; Najvar LK; Bocanegera R; Graybill JR
    J Antimicrob Chemother; 2004 Aug; 54(2):477-80. PubMed ID: 15215225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
    Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
    Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
    Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
    Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2008 Apr; 61(4):880-3. PubMed ID: 18256113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
    Fanci R; Pini G; Bartolesi AM; Pecile P
    Rev Iberoam Micol; 2013 Jan; 30(1):51-3. PubMed ID: 22659590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New development in the treatment of deep-seated mycoses].
    Maesaki S
    Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):1993-8. PubMed ID: 17929445
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.
    Serena C; Pastor FJ; Gilgado F; Mayayo E; Guarro J
    Antimicrob Agents Chemother; 2005 Feb; 49(2):497-502. PubMed ID: 15673724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.